ABSTRACT: Obstructive sleep apnea (OSA) has a high prevalence in the pediatric population and is associated with significant morbidity, both physical and in the realms of development, cognition, behavior, and school performance. Certain subgroups of children are more susceptible to the development of OSA. Although adenotonsillectomy—the most common treatment for childhood OSA—improves symptoms in the majority of patients, a number of children respond less favorably. Positive airway pressure (PAP) is the second most common treatment for childhood OSA. Success in achieving adherence to PAP often requires a stepwise, multidisciplinary approach with close follow-up to address and quickly resolve any problems that arise.
Obstructive sleep apnea (OSA) in children and adolescents is much more prevalent than most practitioners realize: it is found in 1% to 4% of children.1 Moreover, the incidence of pediatric OSA appears to be on the upswing, probably because of the notable increase in childhood and adolescent obesity over the past decade.2 The peak incidence of OSA is seen in children between 3 and 6 years of age,3 around the time that the tonsils and the adenoids reach their maximum size relative to the dimensions of the upper airway. In young children, OSA is equally common in boys and girls, but following the onset of puberty, it is more common in boys.
In this article, I discuss the effects of OSA in children and provide concrete guidance on diagnosing the disorder and ensuring that treatment is as effective as possible.
THE SPECTRUM OF PEDIATRIC OSA
The muscles of the upper airway relax during sleep, leading to a narrowing of its caliber. In addition, the negative pressure generated during inspiration causes the soft tissue of the upper airway to collapse inward. Varying degrees of obstruction can result. With mild obstruction, the only manifestation may be snoring. As the degree of obstruction increases, so does the work of breathing. This tends to result in an increased number of arousals. Arousals in the setting of airflow that remains greater than 50% of baseline constitute what is known as upper airway resistance syndrome. Reductions of airflow to less than 50% of baseline for 2 breath cycles, accompanied by arousal and/or desaturation, are called "hypopneas"; and reductions to less than 10% of baseline are termed "apneas."
Children with obstructed breathing during sleep are less likely to have arousals than are adults. It is not unusual for children—especially younger children—to present instead with obstructive hypoventilation, in which persistent obstruction and decreased airflow lead to carbon dioxide retention and hypoxemia that can persist for minutes without causing an arousal (which might prompt a change in body position, leading to resolution of the obstruction).
CAUSES OF OSA IN CHILDREN
Pediatric OSA is caused by the interaction of many different factors that together result in a critical degree of narrowing and ultimate collapse of the upper airway. Among these are anatomical factors, conditions that result in inflammation of the soft tissue of the upper airway, and reduced baseline central muscle tone of various etiologies4 (Table 1). OSA is also typically worse in the supine position and during rapid eye movement (REM) sleep, when almost all muscle tone except for that of the eye muscles and diaphragm is lost. The large number of possible contributory factors explains why the approach to the treatment of OSA varies from one child to the next.
1. Lumeng JC, Chervin RD. Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:242-252.
2. Kalra M, Inge T, Garcia V, et al. Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery. Obes Res. 2005;13:1175-1179.
3. Rosen CL. Obstructive sleep apnea syndrome (OSAS) in children: diagnostic challenges. Sleep. 1996;19(10 suppl):S274-S277.
4. Wilson SL, Thach BT, Brouillette RT, Abu-Osba YK. Upper airway patency in the human infant: influence of airway pressure and posture. J Appl Physiol. 1980;48:500-504.
5. Arens R, Marcus CL. Pathophysiology of upper airway obstruction: a developmental perspective. Sleep. 2004;27:997-1019.
6. Arens R, McDonough JM, Corbin AM, et al. Upper airway size analysis by magnetic resonance imaging of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2003;167:65-70.
7. Ievers-Landis CE, Redline S. Pediatric sleep apnea: implications of the epidemic of childhood overweight. Am J Respir Crit Care Med. 2007;175:436-441.
8. Arens R, McDonough JM, Costarino AT, et al. Magnetic resonance imaging of the upper airway structure of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2001;164:698-703.
9. Redline S, Tishler P, Aylor J, et al. Prevalence and risk factors for sleep disordered breathing in children [abstract]. Am J Respir Crit Care Med. 1999;155:A843.
10. Gozal D, Kheirandish-Gozal L. Obesity and excessive daytime sleepiness in prepubertal children with obstructive sleep apnea. Pediatrics. 2009;123:13-18.
11. Li AM, Au CT, Sung RY, et al. Ambulatory blood pressure in children with obstructive sleep apnoea—a community based study. Thorax. 2008;63:803-809.
12. Tamura A, Kawano Y, Watanabe T, Kadota J. Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea. Respir Med. 2008;102:1412-1416.
13. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc. 2004;79:1036-1046.
14. Nishibayashi M, Miyamoto M, Miyamoto T, et al. Correlation between severity of obstructive sleep apnea and prevalence of silent cerebrovascular lesions. J Clin Sleep Med. 2008;4:242-247.
15. Halbower AC, Degaonkar M, Barker PB, et al. Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med. 2006;3:e301.
16. Karpinski AC, Scullin MH, Montgomery-Downs HE. Risk for sleep-disordered breathing and executive function in preschoolers. Sleep Med. 2008;9:418-424.
17. Montgomery-Downs HE, Gozal D. Snore-associated sleep fragmentation in infancy: mental development effects and contribution of secondhand cigarette smoke exposure. Pediatrics. 2006;117:e496-e502.
18. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics. 1998;102(3, pt 1):616-620.
19. Chervin RD, Ruzicka DL, Giordani BJ, et al. Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics. 2006;117:e769-e778.
20. Freezer NJ, Bucens IK, Robertson CF. Obstructive sleep apnoea presenting as failure to thrive in infancy. J Paediatr Child Health. 1995;31:172-175.
21. Hogan AM, Hill CM, Harrison D, Kirkham FJ. Cerebral blood flow velocity and cognition in children before and after adenotonsillectomy. Pediatrics. 2008;122:75-82.
22. Kheirandish-Gozal L, Capdevila OS, Tauman R, Gozal D. Plasma C-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med. 2006;2:301-304.
23. Mahboubi S, Marsh RR, Potsic WP, Pasquariello PS. The lateral neck radiograph in adenotonsillar hyperplasia. Int J Pediatr Otorhinolaryngol. 1985;10:67-73.
24. Chesson AL Jr, Ferber RA, Fry JM, et al. The indications for polysomnography and related procedures. Sleep. 1997;20:423-487.
25. Hoban TF. Polysomnography should be required both before and after adenotonsillectomy for childhood sleep disordered breathing. J Clin Sleep Med. 2007;3:675-677.
26. Friedman NR. Polysomnography should not be required both before and after adenotonsillectomy for childhood sleep disordered breathing. J Clin Sleep Med. 2007;3:678-680.
27. Rosen D. Many parents report their child's breathing and sleep patterns during overnight sleep study as atypical. Clin Pediatr (Phila). In press.
28. Mitchell RB, Pereira KD, Friedman NR. Sleepdisordered breathing in children: survey of current practice. Laryngoscope. 2006;116:956-958.
29. Kheirandish L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children. Pediatrics. 2006;117:e61-e66.
30. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005;172:364-370.
31. Mitchell RB, Kelly J. Outcomes and quality of life following adenotonsillectomy for sleep-disordered breathing in children. ORL J Otorhinolaryngol Relat Spec. 2007;69:345-348.
32. Tauman R, Gulliver TE, Krishna J, et al. Persistence of obstructive sleep apnea syndrome in children after adenotonsillectomy. J Pediatr. 2006;149:803-808.
33. Mitchell RB, Kelly J. Outcome of adenotonsillectomy for obstructive sleep apnea in obese and normal-weight children. Otolaryngol Head Neck Surg. 2007;137:43-48.
34. Smith E, Wenzel S, Rettinger G, Fischer Y. Quality of life in children with obstructive sleeping disorder after tonsillectomy, tonsillotomy, or adenotomy [in German]. Laryngorhinootolgie. 2008;87:490-497.
35. American Academy of Pediatrics. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2002;109:704-712.
36. Kushida CA, Chediak A, Berry RB, et al; Positive Airway Pressure Titration Task Force, American Academy of Sleep Medicine. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med. 2008;4:157-171.
37. Lye KW, Waite PD, Meara D, Wang D. Quality of life evaluation of maxillomandibular advancement surgery for treatment of obstructive sleep apnea. J Oral Maxillofac Surg. 2008;66:968-972.
38. Donaldson JD, Redmond WM. Surgical management of obstructive sleep apnea in children with Down syndrome. J Otolaryngol. 1988;17:398-403.
39. Kushida CA, Morgenthaler TI, Littner MR, et al; American Academy of Sleep. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep. 2006;29:240-243.
40. Villa MP, Malagola C, Pagani J, et al. Rapid maxillary expansion in children with obstructive sleep apnea syndrome: 12-month follow-up. Sleep Med. 2007;8:128-134.
41. Monini S, Malagola C, Villa MP, et al. Rapid maxillary expansion for the treatment of nasal obstruction in children younger than 12 years. Arch Otolaryngol Head Neck Surg. 2009;135:22-27.
42. Li KK, Riley RW, Guilleminault C. An unreported risk in the use of home nasal continuous positive airway pressure and home nasal ventilation in children. Chest. 2000;117:916-918.
43. Sher AE. Mechanisms of airway obstruction in Robin sequence: implications for treatment. Cleft Palate Craniofac J. 1992;29:224-231.
44. Johnston C, Taussig LM, Koopmann C, et al. Obstructive sleep apnea in Treacher-Collins syndrome. Cleft Palate J. 1981;18:39-44.
45. Leighton SE, Papsin B, Vellodi A, et al. Disordered breathing during sleep in patients with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol. 2001;58:127-138.
46. Suen JS, Arnold JE, Brooks LJ. Adenotonsillectomy for treatment of obstructive sleep apnea in children. Arch Otolaryngol Head Neck Surg. 1995;121:525-530.
47. Mitchell RB, Call E, Kelly J. Diagnosis and therapy for airway obstruction in children with Down syndrome. Arch Otolaryngol Head Neck Surg. 2003;129:642-645.
48. Mortimore IL, Marshall I, Wraith PK, et al. Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med. 1998;157:280-283.
49. Spitzer AR, Boyle JT, Tuchman DN, Fox WW. Awake apnea associated with gastroesophageal reflux: a specific clinical syndrome. J Pediatr. 1984;104:200-205.
50. Corbo GM, Forastiere F, Agabiti N, et al. Snoring in 9- to 15-year-old children: risk factors and clinical relevance. Pediatrics. 2001;108:1149-1154.
51. Kaditis AG, Finder J, Alexopoulos EI, et al. Sleep-disordered breathing in 3,680 Greek children. Pediatr Pulmonol. 2004;37:499-509.
52. Marcus CL, Keens TG, Bautista DB, et al. Obstructive sleep apnea in children with Down syndrome. Pediatrics. 1991;88:132-139.
53. O'Donoghue FJ, Camfferman D, Kennedy JD, et al. Sleep-disordered breathing in Prader-Willi syndrome and its association with neurobehavioral abnormalities. J Pediatr. 2005;147:823-829.
54. Finnimore AJ, Roebuck M, Sajkov D, McEvoy RD. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J. 1995;8:230-234.
55. Rosen D. Severe hypothyroidism presenting as obstructive sleep apnea. Clin Pediatr (Phila). 2010 Jan 28. [Epub ahead of print]. doi:10.1177/ 0009922809351093.